Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AmSurg Announces Growth in Second-Quarter Net Earnings from Continuing Operations to $0.33 Per Diluted Share; Produces Same-Center Revenue Growth of 5%.


NASHVILLE Nashville, city (1990 pop. 487,969), state capital, coextensive with Davidson co., central Tenn., on the Cumberland River, in a fertile farm area; inc. as a city 1806, merged with Davidson co. 1963. , Tenn. -- Ken P. McDonald, President and Chief Executive Officer of AmSurg Corp. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:AMSG AMSG Air Mobility Support Group (US Air Force)
AMSG Ad Majorem Satanae Gloriam
AMSG Allied Military Security Guidelines
AMSG Advanced Metal Services Group
AMSG Appropriate Military Systems Guide
AMSG American Subterfuge Clothing
), today announced financial results for the second quarter and six months ended June June: see month.  30, 2005. Revenues increased 18% to a record $98,786,000 for the second quarter from $83,739,000 for the second quarter of 2004. Net earnings from continuing operations continuing operations

Parts of a business that are expected to be maintained as an ongoing segment of an overall business operation. Income and losses from continuing operations are reported separately if any segments have been discontinued during the
 rose 28% to $9,986,000 from $7,823,000. Net earnings from continuing operations per diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 share increased 32% for the second quarter of 2005 to $0.33 from $0.25 for the second quarter of 2004. Net earnings from continuing operations for the second quarter of 2004 included a loss from note receivable note receivable

A debt due from borrowers and evidenced by a written promise of payment. Note receivable, an entry on the asset side of many corporate balance sheets, indicates the dollar amount of loans due to be repaid by borrowers.
 of $0.02 per diluted share.

For the first six months of 2005, revenues increased 17% to $190,601,000 from $162,745,000 for the first six months last year. Net earnings from continuing operations were $18,685,000, up 19% from $15,669,000. Net earnings from continuing operations per diluted share rose 22% to $0.62 for the first half of 2005 from $0.51 for the comparable period in 2004.

"AmSurg produced continued earnings growth for the second quarter of 2005," remarked Mr. McDonald. "We primarily attribute (1) In relational database management, a field within a record.

(2) In object technology, a single element of data. See instance attribute and static attribute.
 this growth to the expansion of the number of our centers in operation to 140 at the end of the second quarter from 116 at the same time in 2004. The addition of 24 new centers during the 12 months ended June 30, 2005 strengthens our confidence in our ability to achieve our new center target for 2005 of adding 16 to 19 centers. We are also pleased to report an increase of 5% in same-facility revenue for the quarter, primarily driven by procedure growth.

"During the second quarter, we added six new centers in operation and sold one nonperforming center. Three of the six additional centers were acquisitions completed late in the quarter, and the remaining three were de novo [Latin, Anew.] A second time; afresh. A trial or a hearing that is ordered by an appellate court that has reviewed the record of a hearing in a lower court and sent the matter back to the original court for a new trial, as if it had not been previously heard nor decided.  centers. As a result of this opening activity, we have added 13 new centers through the first half of 2005, approaching our 16 to 19 center target additions for 2005. Through June 30, 2005, we have opened five of the eight de novo centers scheduled for 2005, and we have completed the acquisitions of eight of our targeted acquisitions for the year.

"We finished the second quarter with five centers under development, including the execution of one agreement during the quarter for a G.I. center to be opened in 2006. We also had four signed letters of intent for acquisitions at the quarter's end. Because of the progress-to-date toward completion of the remaining three de novo centers scheduled to open in 2005 and the continuing strength of our pipeline of potential acquisitions, we remain confident of achieving our overall center opening guidance for 2005.

"The second quarter extended our long-term Long-term

Three or more years. In the context of accounting, more than 1 year.


long-term

1. Of or relating to a gain or loss in the value of a security that has been held over a specific length of time. Compare short-term.
 record of growth, including 30 consecutive quarters of positive same-facility revenues. Based on our year-to-date Year-to-date (YTD)

The period beginning at the start of the calendar year up to the current date.
 results and our expectations for the second half of the year, we have refined our guidance and narrowed the range for net earnings from continuing operations per diluted share for 2005 to a range of $1.33 to $1.34. This guidance includes our assumptions for revenues in a range of $400 million to $420 million for 2005 and growth in same-facility revenues for the remainder of the year in a range of 4% to 7%.

Mr. McDonald concluded, "The second quarter was a positive indicator Indicator

Anything used to predict future financial or economic trends.

Notes:
In the context of technical analysis, an indicator is a mathematical calculation based on a securities price and/or volume. The result is used to predict future prices.
 with regard to our same-facility revenues. We will continue working closely with our physician partners to increase market share and thereby support further gains in same-facility revenues. We are also focused on achieving our center opening goals for 2005. As a result, we are confident AmSurg is well positioned to meet its financial objectives for 2005."

The information contained in the preceding paragraphs is forward-looking for·ward-look·ing
adj.
Concerned with or making provision for the future: forward-looking educators; a forward-looking corporate plan.

Adj. 1.
 information, and the attainment of these targets is dependent not only on AmSurg's achievement of its assumptions discussed above, but also on the risks and uncertainties listed below that could cause actual results, performance or developments to differ materially from those expressed or implied Inferred from circumstances; known indirectly.

In its legal application, the term implied is used in contrast with express, where the intention regarding the subject matter is explicitly and directly indicated.
 by this forward-looking information.

AmSurg Corp. will hold a conference call to discuss this release today at 5:00 p.m. Eastern time. Investors will have the opportunity to listen to the conference call over the Internet Internet

Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the
 by going to www.amsurg.com and clicking "Investor Relations Investor relations

The process by which the corporation communicates with its investors.
" or by going to www.streetevents.com at least 15 minutes early to register, download To receive a file transmitted over a network. In any communications session, "download" means receive, and "upload" means send. The download/upload often implies a big/little scenario, in which data is being downloaded from the "big" server into the "little" user's computer. , and install any necessary audio software. For those who cannot listen to the live broadcast, a replay will be available at these sites shortly after the call through the end of business on August 26, 2005.

This press release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
. These statements, which have been included in reliance on the "safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995, involve risks and uncertainties. Investors are hereby cautioned that these statements may be affected by the important factors, among others, set forth in AmSurg's Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the fiscal year ended December December: see month.  31, 2004, and other filings with the Securities and Exchange Commission, including the following risks: the Company's ability to enter into partnership or operating agreements An operating agreement is an agreement among limited liability company ("LLC") members governing the LLC's business, and Member's financial and management rights and duties. No state requires an LLC to have an Operating agreement.  for new practice-based ambulatory surgery centers ambulatory surgery center A free-standing center that performs various types of surgery ; its ability to identify suitable acquisition candidates and negotiate and close acquisition transactions, including centers under letter of intent; its ability to obtain the necessary financing or capital on terms satisfactory to the Company to execute To run a program, which causes the computer to carry out its instructions. See executable code, instruction and EXE file.

execute - execution
 its expansion strategy; its ability to generate and manage growth at the Company's existing centers and through acquisitions and development of new centers; its ability to contract with managed care payers on terms satisfactory to the Company for its existing centers and its centers that are currently under development; its ability to obtain and retain appropriate licensing approvals for its existing centers and centers currently under development; its ability to minimize In a graphical environment, to hide an application that is currently displayed on screen. For example, in Windows and Mac, the application's window is removed from the screen and represented by an icon on the Windows Taskbar. In the Mac, the icon is placed in the Dock. See Win Minimize windows.  start-up Start-up

The earliest stage of a new business venture.
 losses of its development centers; the ability of its physician partners to recruit RECRUIT. A newly made soldier.  additional physicians to their practices; its ability to maintain favorable fa·vor·a·ble  
adj.
1. Advantageous; helpful: favorable winds.

2. Encouraging; propitious: a favorable diagnosis.

3.
 relations with its physician partners; changes in the medical staff at its centers; changes in the rate setting methodology, payment rates, payment policies and the list of covered surgical procedures Surgical procedures have long and possibly daunting names. The meaning of many surgical procedure names can often be understood if the name is broken into parts. For example in splenectomy, "ectomy" is a suffix meaning the removal of a part of the body. "Splene-" means spleen.  for ambulatory surgery centers by the Centers for Medicare Medicare, national health insurance program in the United States for persons aged 65 and over and the disabled. It was established in 1965 with passage of the Social Security Amendments and is now run by the Centers for Medicare and Medicaid Services.  & Medicaid Medicaid, national health insurance program in the United States for low-income persons; established in 1965 with passage of the Social Security Amendments and now run by the Centers for Medicare and Medicaid Services.  Services; the risk of legislative or regulatory reg·u·late  
tr.v. reg·u·lat·ed, reg·u·lat·ing, reg·u·lates
1. To control or direct according to rule, principle, or law.

2.
 changes that would establish uniform rates for outpatient outpatient /out·pa·tient/ (-pa-shent) a patient who comes to the hospital, clinic, or dispensary for diagnosis and/or treatment but does not occupy a bed.

out·pa·tient
n.
 surgical services, regardless of setting; risks associated with the Company's status as a general partner of limited partnerships; the Company's ability to maintain its technological capabilities in compliance with regulatory requirements Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country. ; risks associated with the valuation and tax deductibility of goodwill; the risk of legislative or regulatory changes that would prohibit pro·hib·it  
tr.v. pro·hib·it·ed, pro·hib·it·ing, pro·hib·its
1. To forbid by authority: Smoking is prohibited in most theaters. See Synonyms at forbid.

2.
 physician ownership in ambulatory surgery centers; and the Company's ability to obtain the necessary financing to fund the purchase of its physician partners' minority interest in the event of a regulatory change that would require such a purchase. Consequently, actual operations and results may differ materially from the forward-looking statements included above. AmSurg disclaims any intent or obligation to update these forward-looking statements.

AmSurg Corp. develops, acquires and manages physician practice-based ambulatory surgery centers in partnership with surgical and other group practices. At June 30, 2005, AmSurg owned a majority interest in 140 centers and had five centers under development.
AMSURG CORP.
     Unaudited Selected Consolidated Financial and Operating Data
           (Dollars in thousands, except per share amounts)


                              For the Three Months  For the Six Months
                                  Ended June 30,      Ended June 30,
                               ------------------- -------------------
Statement of Earnings Data:        2005      2004      2005      2004
---------------------------    --------- --------- --------- ---------

Revenues                        $98,786   $83,739  $190,601  $162,745

Operating expenses:
 Salaries and benefits           26,878    22,110    52,717    43,547
 Supply cost                     10,936     9,429    21,017    18,316
 Other operating expenses        19,429    17,868    37,830    33,325
 Depreciation and
  amortization                    3,894     3,218     7,561     6,338
                               --------- --------- --------- ---------

  Total operating expenses       61,137    52,625   119,125   101,526
                               --------- --------- --------- ---------

  Operating income               37,649    31,114    71,476    61,219

Minority interest                20,242    17,582    38,870    34,195
Interest expense, net               983       494     1,873       910
                               --------- --------- --------- ---------

  Earnings from continuing
   operations before income
   taxes                         16,424    13,038    30,733    26,114
Income tax expense                6,438     5,215    12,048    10,445
                               --------- --------- --------- ---------

  Net earnings from continuing
   operations                     9,986     7,823    18,685    15,669

Discontinued operations:
 Earnings (loss) from
  operations of discontinued
  interests in surgery
  centers, net of income taxes      (61)      411      (108)      944
 Gain (loss) on disposal of
  discontinued interests in
  surgery centers, net of
  income taxes                     (243)        -      (243)    1,241
                               --------- --------- --------- ---------

  Earnings (loss) from
   discontinued operations         (304)      411      (351)    2,185
                               --------- --------- --------- ---------

  Net earnings                   $9,682    $8,234   $18,334   $17,854
                               ========= ========= ========= =========

Basic earnings per common
 share:
  Net earnings from continuing
   operations                     $0.34     $0.26     $0.63     $0.52
  Net earnings                    $0.33     $0.27     $0.62     $0.59
Diluted earnings per common
 share:
  Net earnings from continuing
   operations                     $0.33     $0.25     $0.62     $0.51
  Net earnings                    $0.32     $0.27     $0.61     $0.58

Weighted average number of
 shares and share equivalents
 (000's):
 Basic                           29,537    30,238    29,494    30,198
 Diluted                         30,165    30,862    30,094    30,847

Operating Data:
---------------

Continuing centers in
 operation at end of period         140       116       140       116
Centers under development/not
 opened at end of period              5        13         5        13
Centers under letter of
 intent                               4         6         4         6
Average number of centers in
 operation                          135       115       133       114
Average revenue per center         $731      $728    $1,437    $1,433
Same center revenues
 increase                             5%        5%        4%        6%
Procedures performed during
 the period                     187,615   153,253   358,853   298,446
Cash flows provided by
 operating activities           $12,550   $11,095   $30,877   $26,185
Cash flows used by investing
 activities                    $(18,799) $(17,170) $(40,621) $(29,605)
Cash flows provided by (used
 in) financing activities        $6,684    $6,060   $11,845    $4,525
Reconciliation of net earnings
 to EBITDA (1):
 Net earnings from continuing
  operations                     $9,986    $7,823   $18,685   $15,669
 Add: income tax expense          6,438     5,215    12,048    10,445
 Add: interest expense, net         983       494     1,873       910
 Add: depreciation and
  amortization                    3,894     3,218     7,561     6,338
                               --------- --------- --------- ---------

  EBITDA                        $21,301   $16,750   $40,167   $33,362
                               ========= ========= ========= =========




                             AMSURG CORP.
     Unaudited Selected Consolidated Financial and Operating Data
                            (In thousands)


                                               June 30,   December 31,
Balance Sheet Data:                              2005         2004
-------------------                           -----------  -----------

Cash and cash equivalents                    $    17,093  $    14,992
Accounts receivable, net                          44,342       39,224
Working capital                                   61,440       56,302
Total assets                                     464,439      425,155
Long-term debt and other long-term
 liabilities                                      98,814       88,160
Minority interest                                 43,972       39,710
Shareholders' equity                             275,664      254,149


(1) EBITDA is defined as earnings before interest, income taxes and
    depreciation and amortization. EBITDA should not be considered a
    measure of financial performance under generally accepted
    accounting principles. Items excluded from EBITDA are significant
    components in understanding and assessing financial performance.
    EBITDA is an analytical indicator used by management and the
    health care industry to evaluate company performance, allocate
    resources and measure leverage and debt service capacity. EBITDA
    should not be considered in isolation or as alternatives to net
    income, cash flows generated by operations, investing or financing
    activities, or other financial statement data presented in the
    consolidated financial statements as indicators of financial
    performance or liquidity. Because EBITDA is not a measurement
    determined in accordance with generally accepted accounting
    principles and is thus susceptible to varying calculations, EBITDA
    as presented may not be comparable to other similarly titled
    measures of other companies. Net earnings from continuing
    operations is the financial measure calculated and presented in
    accordance with generally accepted accounting principles that is
    most comparable to EBITDA as defined.



                             AMSURG CORP.
     Unaudited Selected Consolidated Financial and Operating Data
                            (In thousands)

Presented below is certain statement of earnings and operating data
for 2005 and 2004, which has been restated in order to conform to the
current year presentation, which reflects operating results from
continuing and discontinued operations.


                                                              For the
                         For the Three Months Ended              Year
                --------------------------------------------    Ended
Statement of    Mar. 31, Mar. 31, June 30, Sept. 30, Dec. 31, Dec. 31,
 Earnings Data:    2005     2004     2004     2004     2004      2004
--------------- -------- -------- -------- -------- -------- ---------

Revenues        $91,815  $79,006  $83,739  $81,277  $87,800  $331,822

Operating
 expenses:
  Salaries and
   benefits      25,839   21,437   22,110   21,914   23,927    89,388
  Supply cost    10,081    8,887    9,429    9,040   10,206    37,562
  Other
   operating
   expenses      18,401   15,457   17,868   15,613   18,013    66,951
  Depreciation
   and
   amortization   3,667    3,120    3,218    3,315    3,558    13,211
                -------- -------- -------- -------- -------- ---------

      Total
       operating
       expenses  57,988   48,901   52,625   49,882   55,704   207,112
                -------- -------- -------- -------- -------- ---------

      Operating
       income    33,827   30,105   31,114   31,395   32,096   124,710

Minority
 interest        18,628   16,613   17,582   16,340   17,299    67,834
Interest
 expense, net       890      416      494      477      699     2,086
                -------- -------- -------- -------- -------- ---------

      Earnings
       from
       continuing
       operations
       before
       income
       taxes     14,309   13,076   13,038   14,578   14,098    54,790
Income tax
 expense          5,610    5,230    5,215    5,831    5,402    21,678
                -------- -------- -------- -------- -------- ---------

      Net earnings
       from
       continuing
       operations 8,699    7,846    7,823    8,747    8,696    33,112

Discontinued
 operations:
  Earnings (loss)
   from operations
   of discontinued
   interests in
   surgery centers,
   net of income
   taxes            (47)     533      411       87      (35)      996
  Gain on disposal
   of discontinued
   interests in
   surgery centers,
   net of income
   taxes              -    1,241        -    4,332       25     5,598
                -------- -------- -------- -------- -------- ---------

      Earnings
       (loss)
       from
       discontinued
       operations   (47)   1,774      411    4,419      (10)    6,594
                -------- -------- -------- -------- -------- ---------

      Net
       earnings  $8,652   $9,620   $8,234  $13,166   $8,686   $39,706
                ======== ======== ======== ======== ======== =========

Basic earnings per
 common share:
      Net earnings
       from
       continuing
       operations $0.30    $0.26    $0.26    $0.29    $0.30     $1.11
      Net
       earnings   $0.29    $0.32    $0.27    $0.44    $0.30     $1.33
Diluted earnings
 per common share:
      Net earnings
       from
       continuing
       operations $0.29    $0.25    $0.25    $0.29    $0.29     $1.09
      Net
       earnings   $0.29    $0.31    $0.27    $0.43    $0.29     $1.30

Weighted average
 number of shares
 and share
 equivalents
 (000's):
  Basic          29,451   30,158   30,238   29,886   29,299    29,895
  Diluted        30,024   30,832   30,862   30,454   29,880    30,507

Operating Data:
---------------

Procedures      171,238  145,193  153,253  150,850  161,442   610,738
Reconciliation
 of net earnings
 to EBITDA (1):
  Net earnings
   from
   continuing
   operations    $8,699   $7,846   $7,823   $8,747   $8,696   $33,112
  Add:  income
   tax expense    5,610    5,230    5,215    5,831    5,402    21,678
  Add:  interest
   expense, net     890      416      494      477      699     2,086
  Add:
   depreciation
   and
   amortization   3,667    3,120    3,218    3,315    3,558    13,211
                -------- -------- -------- -------- -------- ---------

      EBITDA    $18,866  $16,612  $16,750  $18,370  $18,355   $70,087
                ======== ======== ======== ======== ======== =========

COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 26, 2005
Words:2477
Previous Article:The Corporate Executive Board Reports Second-Quarter Earnings of $0.41 Per Diluted Share and 30% Revenue Growth.
Next Article:Manhattan Associates Reports Results for the Second Quarter of 2005; Company Realizes Record License and Services Revenue for the Second Consecutive...
Topics:



Related Articles
AmSurg Corp. Reports Third Quarter Earnings Increase 50% to $0.12 Per Share; Achieves 5th Consecutive Quarter of Double-Digit Growth in Same-Center...
AmSurg Corp. Reports 30% Growth in Fourth Quarter Earnings to $0.13 Per Share; Full Year Earnings Per Share Increases to $0.48.
AmSurg Corp. Earns $0.15 Per Share for the Second Quarter of 2000 On a 40% Increase in Revenues; Same-center Revenues Again Increase 10%.
AmSurg 4th-Quarter Earnings Increase 31% to $0.17 Per Diluted Share; Same-Center Revenues Increase 11%.
AmSurg's Second-Quarter Earnings Increase 27% to $0.19 Per Diluted Share; Revenues Grow 43%; Net Earnings 68%.
AmSurg Corp. Announces 27% Growth in Third Quarter; Earnings Per Share to $0.19.
AmSurg Reports 23% Growth in Net Earnings Per Diluted Share from Continuing Operations to $0.27; First-Quarter Same-Center Revenues Increase 7%.
AmSurg Announces Second-Quarter Results.
AmSurg Reports Second-Quarter Net Earnings Per Diluted Share of $0.33 on 22% Growth in Revenues; Same-Center Revenues Increase 5%.
AmSurg Earns $0.33 Per Diluted Share from Fourth-Quarter Continuing Operations.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles